Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner.

Local charity provides funds for cancer and haematology research

Dr Ian Fleming (back left) with Dr Kirsten Laws (back middle) and PhD students are Andrew Mohan (front) and Bandar Alwadani (back right)
Dr Ian Fleming (back left) with Dr Kirsten Laws (back middle) and PhD students are Andrew Mohan (front) and Bandar Alwadani (back right)

The Friends of Anchor charity is preparing to invest a considerable sum in pioneering cancer research projects.

It has made £90,000 available for early seed funding and is now seeking applicants to benefit from individual grants of up to £15,000.

The charity funds research into cancer and haematology every year and applications are now open for professionals working within NHS Grampian, the University of Aberdeen and Robert Gordon University.

Professor Henry Watson, consultant haematologist and Friends of Anchor committee member, said: “Without funding such as this, the university scientist might be sitting on a potentially brilliant project but may not have access to the initial pilot funding to test their hypothesis.

“That is why for several years Friends of Anchor has provided this important resource.”

Pilot projects funded over the past year include studies into bowel cancer, leukaemia and sickle cell anaemia.

Ultimately, the hope is that the data from these pilot studies results in a higher rate of success in larger applications for external funding from a major funding body.

One of the most recent beneficiaries of Friends of Anchor’s support is Dr Ian Fleming, whose research has given scientists a better understanding of how new targeted cancer drugs could be developed to prevent the growth and spread of tumours.

He said: “The results of our pilot study uncovered the potential for further work that could lead to a new class of drugs to combat metastases.

“This could translate into a significant positive effect on survival outcomes in cancer patients.”

Applications for pilot research are open until April 1, 2020, and should be submitted to info@friendsofanchor.org.

Already a subscriber? Sign in

[[title]]

[[text]]